Implementation of endovenous laser ablation for varicose veins in a large community hospital: the first 400 procedures

European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
J van den BremerF L Moll

Abstract

Endovenous laser ablation (ELA) has become a standard treatment of the incompetent great saphenous vein (GSV). Our prospective audit examines the implementation of this new method in a large community hospital with special attention to obstacles, technical results, pain scores, failures and our learning curve. Three hundred and twenty-three patients (403 limbs) with incompetence of the GSV underwent ELA. Patients were assessed by clinical examination and venous duplex ultrasound was performed 6 weeks after operation. Visual analog scale (VAS) pain scores of the first postoperative week were recorded. Operative time and success rate were analysed. After 6 weeks, 301 (74.7%) treated legs were examined by duplex ultrasound imaging. Successful complete occlusion was present in 282 (93.7%) GSVs. Partial occlusion was present in 12 (4.0%) GSVs. In seven (2.3%) limbs the GSV was not occluded. The maximum mean VAS pain score was noted on the 5th postoperative day. From the start of this series, the operation time decreased rapidly for each surgeon, stabilising after 15 limbs. ELA of the incompetent GSV is effective and safe. ELA is simple to perform, well accepted by patients and relatively atraumatic. In our opinion, ELA can be easily...Continue Reading

References

Sep 1, 1992·European Journal of Vascular Surgery·S G Darke
Feb 1, 1994·The British Journal of Surgery·M J Callam
Oct 5, 2001·Journal of Vascular and Interventional Radiology : JVIR·R J MinM D Forrestal
Jul 24, 2002·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·T M ProebstleH A Lehr
Mar 27, 2003·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Thomas M ProebstleJuergen Knop
Aug 7, 2003·Journal of Vascular and Interventional Radiology : JVIR·Robert J MinSteven E Zimmet
Aug 30, 2003·Journal of Vascular Surgery·T M ProebstleJ Knop
Feb 5, 2004·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·L BlomgrenD Bergqvist
Aug 7, 2004·Journal of Vascular Surgery·André M van RijPing Jiang
Nov 9, 2004·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·Y El WajehP Chan
Mar 26, 2005·Seminars in Vascular Surgery·Tim Cheatle
May 4, 2005·The International Journal of Lower Extremity Wounds·Rosie J BealeMichael J Gough
Jun 4, 2005·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·R J Beale, M J Gough
Jun 11, 2005·Journal of Vascular and Interventional Radiology : JVIR·Paul E Timperman
Sep 22, 2005·The British Journal of Surgery·L MundyJ E Hiller
Oct 11, 2005·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·W B CampbellA R Cowan
Oct 16, 2007·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·N S TheivacumarM J Gough
Dec 25, 2007·Journal of Vascular Surgery·Jacques DesmyttèreSerge Mordon

❮ Previous
Next ❯

Citations

Jun 15, 2011·Photomedicine and Laser Surgery·Mehmet Umit ErgenogluDeniz Suha Kucukaksu
Feb 11, 2010·Annals of Vascular Surgery·Jephta van den Bremer, Frans L Moll
Apr 15, 2015·Seminars in Vascular Surgery·Ramon R J P van EekerenMichel M P J Reijnen
Jul 21, 2010·Vascular·Ranjeet BrarMatthew M Thompson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.